Tissue Factor Signals Airway Epithelial Basal Cell Survival via Coagulation and PAR1/2.

Department of Pediatrics, National Jewish Health, Denver, Colorado, United States.
American Journal of Respiratory Cell and Molecular Biology (Impact Factor: 4.11). 10/2012; DOI: 10.1165/rcmb.2012-0189OC
Source: PubMed

ABSTRACT Rationale: Tissue factor (TF) initiates the extrinsic coagulation cascade and is a high affinity receptor for coagulation factor VII. TF also participates in Protease Activated Receptor, PAR1 and PAR2, activation. Human epithelial basal cells were previously purified on the basis of tissue factor (TF) expression. Objective: The purpose of this study was to determine if tracheobronchial epithelial basal cell-associated TF drives coagulation and/or activates PARs to promote basal cell functions. Methods: We utilized human tracheobronchial tissues to isolate human airway epithelial cells using specific cell surface markers by flow cytometry and studied TF expression by immunostaining. TF-dependent fibrin network formation was observed by confocal and scanning electron microscopy (SEM). TF knockdown was done using shRNA, and TF mRNA was measured using quantitative RT-PCR. Results: We found that 97±5% of first passage human tracheobronchial epithelial cells were basal cells, and 100% of these basal cells expressed TF. Basal cell-associated TF was active, but TF activity was dependent on added extrinsic coagulation cascade factors. TF inhibition caused basal cell apoptosis and necrosis. This was due to two parallel but interdependent TF-regulated processes: failure to generate a basal cell-associated fibrin network and suboptimal PAR1/2 activity. Conclusions: The data indicates that membrane surface TF mediates airway epithelial basal cell attachment, which maintains cell survival and mitotic potential. The implications of these findings are discussed in the context of basal cell-associated TF activity in normal and injured tissues, and potential for repair of airway epithelium in lung disease.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Hypoxia and HIF-2α-dependent A2A receptor expression and activation increase proliferation of human lung microvascular endothelial cells (HLMVECs). This study was undertaken to investigate the signaling mechanisms that mediate the proliferative effects of A2A receptor. A2A receptor-mediated proliferation of HLMVECs was inhibited by intracellular calcium chelation, and by specific inhibitors of ERK1/2 and PI3-kinase (PI3K). The adenosine A2A receptor agonist CGS21680 caused intracellular calcium mobilization in controls and, to a greater extent, in A2A receptor-overexpressing HLMVECs. Adenoviral-mediated A2A receptor overexpression as well as receptor activation by CGS21680 caused increased PI3K activity and Akt phosphorylation. Cells overexpressing A2A receptor also manifested enhanced ERK1/2 phosphorylation upon CGS21680 treatment. A2A receptor activation also caused enhanced cAMP production. Likewise, treatment with 8Br-cAMP increased PI3K activity. Hence A2A receptor-mediated cAMP production and PI3K and Akt phosphorylation are potential mediators of the A2A-mediated proliferative response of HLMVECs. Cytosolic calcium mobilization and ERK1/2 phosphorylation are other critical effectors of HLMVEC proliferation and growth. These studies underscore the importance of adenosine A2A receptor in activation of survival and proliferative pathways in pulmonary endothelial cells that are mediated through PI3K/Akt and ERK1/2 pathways.
    Biochemical and Biophysical Research Communications 04/2013; 434(3). DOI:10.1016/j.bbrc.2013.03.115 · 2.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A conference, "Stem Cells and Cell Therapies in Lung Biology and Lung Diseases", was held July 25-28, 2011 at the University of Vermont, to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy and ex vivo bioengineering approaches for lung diseases. These are rapidly expanding areas of study that both provide further insight into and challenge traditional views of mechanisms of lung repair after injury and pathogenesis of several lung diseases. The goals of the conference were to summarize the current state of the field, discuss and debate current controversies, and to identify future research directions and opportunities for both basic and translational research in cell based therapies for lung diseases. The goal of this article, which accompanies the formal conference report, is to provide a comprehensive review of the published literature in lung regenerative medicine from the last conference report through December 2012.
    07/2013; DOI:10.1513/AnnalsATS.201304-090AW
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rational: Human tracheobronchial epithelial (TBE) basal cells (BC) function as progenitors in normal tissue. However, mechanistic studies are typically performed in vitro and frequently use BC recovered from patients that die of non-respiratory disease. It is not known if the cadaveric epithelium: 1) is undergoing homeostatic remodeling and/or repair; or 2) yields BC clones that represent homeostatic processes identified in tissue. Objective: To compare the phenotype of TBE-BC with that of BC cultured under optimal clone-forming conditions. Methods: TBE pathology was evaluated using quantitative histomorphometry. Cultured BC phenotype was determined by FACS analysis. Clone organization and cell phenotype was determined by immunostaining. Results: The cadaveric TBE is 20% normal. In these regions, BC are keratin (K) 5+ and tetraspanin CD151+, and have a low mitotic index. In contrast, 80% of the cadaveric TBE exhibits homeostatic remodeling/repair processes. In these regions, BC are K5+/K14+ and a subset expresses tissue factor (TF). Passage 1 TBE cells are BC that are K5+/TF+, and half co-express CD151. Optimal clone formation conditions utilize an irradiated NIH3T3 fibroblast feeder layer and serum-supplemented Epicult-BTM medium. The TF+/CD151- BC subpopulation is the most clonogenic BC subtype and is enriched with K14+ cells. TF+/CD151- BC generate clones that contain BC that are K5+/Trp63+ but K14-/CD151-. TF+ cells are limited to the clone edge. Conclusion: Clonogenic human TBE BC: 1) exhibit a molecular phenotype that is a composite of the normal and remodeling/reparative basal cell phenotypes observed in tissue; and 2) generate organoid clones that contain phenotypically distinct BC subpopulations.
    American Journal of Respiratory Cell and Molecular Biology 08/2013; DOI:10.1165/rcmb.2013-0049OC · 4.11 Impact Factor